Gian Life Care (BOM:542918) ROCE % : 4.71% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gian Life Care ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gian Life Care's annualized ROCE % for the quarter that ended in Sep. 2024 was 4.71%.

Gian Life Care ROCE % Historical Data

The historical data trend for Gian Life Care's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gian Life Care ROCE % Chart

Gian Life Care Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

38.51

32.17

46.62

12.01

31.03

Gian Life Care Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Sep20	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial														7.88	50.41	55.25	4.87	4.71

Gian Life Care ROCE % Calculation

Gian Life Care's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	62.111	/	( ( (282.431 - 107.791)	+	(326.357 - 100.617) )	/ 2 )
	=	62.111	/	( (174.64	+	225.74)	/ 2 )
	=	62.111	/	200.19
	=	31.03 %

Gian Life Care's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	10.712	/	( ( (0 - 0)	+	(343.461 - 115.968) )	/ 1 )
	=	10.712	/	( ( 0	+	227.493 )	/ 1 )
	=	10.712	/	227.493
	=	4.71 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Gian Life Care (BOM:542918) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gian Life Care ROCE % Related Terms

Thank you for viewing the detailed overview of Gian Life Care's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gian Life Care Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gian Life Care Ltd (BOM:542918) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7/216 (6) Swaroop Nagar, Infront of L-L.R. Hospital, Kanpur, UP, IND, 208002

Website

https://www.gianlifecare.org

Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The Company has only one operating segment namely, Laboratories Pathological Investigations.

Gian Life Care Headlines

No Headlines